176 related articles for article (PubMed ID: 38093705)
1. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma.
He J; Miao R; Chen Y; Wang H; Liu M
Immunology; 2024 Apr; 171(4):445-463. PubMed ID: 38093705
[TBL] [Abstract][Full Text] [Related]
2. Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma.
Bai Q; Li R; He X; Hong X; Yan Y; Zhao Z; Lin H; Tacke F; Engelmann C; Hu T
Front Immunol; 2023; 14():1320414. PubMed ID: 38116005
[TBL] [Abstract][Full Text] [Related]
3. The Adaptive Immune Response in Hepatitis B Virus-Associated Hepatocellular Carcinoma Is Characterized by Dysfunctional and Exhausted HBV-Specific T Cells.
Broholm M; Mathiasen AS; Apol ÁD; Weis N
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793588
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.
Li W; Han J; Wu H
Chronic Dis Transl Med; 2016 Jun; 2(2):67-80. PubMed ID: 29063027
[TBL] [Abstract][Full Text] [Related]
6. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma.
Sun R; Li J; Lin X; Yang Y; Liu B; Lan T; Xiao S; Deng A; Yin Z; Xu Y; Xiang Z; Wu B
Front Immunol; 2023; 14():1079495. PubMed ID: 37077908
[TBL] [Abstract][Full Text] [Related]
7. Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs.
Kondo Y; Shimosegawa T
Int J Mol Sci; 2015 Feb; 16(2):3307-22. PubMed ID: 25654227
[TBL] [Abstract][Full Text] [Related]
8. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Cho HJ; Cheong JY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360777
[TBL] [Abstract][Full Text] [Related]
9. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models.
Kosinska AD; Pishraft-Sabet L; Wu W; Fang Z; Lenart M; Chen J; Dietze KK; Wang C; Kemper T; Lin Y; Yeh SH; Liu J; Dittmer U; Yuan Z; Roggendorf M; Lu M
Hepatology; 2017 Jul; 66(1):69-83. PubMed ID: 28295453
[TBL] [Abstract][Full Text] [Related]
10. The positive feedback loop of furin and TGFβ1 enhances the immune responses of Tregs to hepatocellular carcinoma cells and hepatitis B virus in vitro.
Qiu H; Wang N; Lin D; Yuan Y; Li J; Mao D; Meng Y
Cell Biol Int; 2022 Aug; 46(8):1215-1226. PubMed ID: 35349767
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Mitochondrial Metabolism by Hepatitis B Virus.
Li Y; Ou JJ
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140600
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Sharma S; Khosla R; David P; Rastogi A; Vyas A; Singh D; Bhardwaj A; Sahney A; Maiwall R; Sarin SK; Trehanpati N
Front Immunol; 2015; 6():49. PubMed ID: 25767469
[TBL] [Abstract][Full Text] [Related]
13. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
[TBL] [Abstract][Full Text] [Related]
14. Immune Regulation by T Regulatory Cells in Hepatitis B Virus-Related Inflammation and Cancer.
Trehanpati N; Vyas AK
Scand J Immunol; 2017 Mar; 85(3):175-181. PubMed ID: 28109025
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
[TBL] [Abstract][Full Text] [Related]
16. Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice.
Stross L; Günther J; Gasteiger G; Asen T; Graf S; Aichler M; Esposito I; Busch DH; Knolle P; Sparwasser T; Protzer U
Hepatology; 2012 Sep; 56(3):873-83. PubMed ID: 22487943
[TBL] [Abstract][Full Text] [Related]
17. Immune suppression in chronic hepatitis B infection associated liver disease: A review.
Li TY; Yang Y; Zhou G; Tu ZK
World J Gastroenterol; 2019 Jul; 25(27):3527-3537. PubMed ID: 31367154
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection.
Trehanpati N; Shrivastav S; Shivakumar B; Khosla R; Bhardwaj S; Chaturvedi J; Sukriti ; Kumar B; Bose S; Mani Tripathi D; Das T; Sakhuja P; Rastogi A; Bhihari C; Singh S; Gupta S; Kottilil S; Sarin SK
Clin Transl Gastroenterol; 2012 Oct; 3(10):e23. PubMed ID: 23238065
[TBL] [Abstract][Full Text] [Related]
19. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
20. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
